SCHEMBL8326253

SCHEMBL8326253

CCOC(=O)c1[nH]c(C)c(-c2nc(Nc3ccccc3)ncc2C#N)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.50
CDK2 P24941 4/20 0.49
CCNE1 P24864 1/20 0.49
FLT3 P36888 1/20 0.49
CDK7 P50613 1/20 0.49
CCNH P51946 1/20 0.49
MNAT1 P51948 1/20 0.49
CDK1 P06493 8/20 0.48
CCNA2 P20248 3/20 0.47
CDK4 P11802 2/20 0.47
CCND3 P30281 2/20 0.47
CCNA1 P78396 1/20 0.47
CDK6 Q00534 1/20 0.47
MAP2K1 Q02750 1/20 0.43
CSF1R P07333 1/20 0.42
AURKA O14965 1/20 0.41
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 2/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8316804 0.79 CDK4 (0.59) CDK2CDK4ALDH1A1NPC1RAB9A
SCHEMBL8323641 0.74 CA2 (0.46) KDRCDK2CCNE1CDK7CCNH
SCHEMBL14011223 0.71 CDK4 (0.50) CDK2CDK4
SCHEMBL13987853 0.70 CYP1A2 (0.43) ALDH1A1MAPTRAB9AKMT2A
SCHEMBL13852053 0.70 CDK2 (0.72) CDK2CCNE1CDK7CCNHCDK1
SCHEMBL8317365 0.69 CDK2 (0.60) CDK2CDK4ALDH1A1MAPTKMT2A
SCHEMBL8317316 0.69 CDK2 (0.74) CDK2CDK4ALDH1A1NPC1RAB9A
SCHEMBL8324564 0.69 CDK4 (0.66) KDRCDK2CDK4NPC1RAB9A
SCHEMBL6033235 0.69 KDR (0.72) KDRCDK1ALDH1A1RAB9A
SCHEMBL6033918 0.69 KDR (1.00) KDRCDK1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456190-B2 Compositions useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-25 US disclosed
US-7456190-B2 Compositions useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-25 US disclosed
WO-2004083203-A1 COMPOSITIONS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-09-30 WO disclosed